financetom
Business
financetom
/
Business
/
SpiceJet to offer insurance up to Rs 3 lakh for COVID-19 treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SpiceJet to offer insurance up to Rs 3 lakh for COVID-19 treatment
Jul 8, 2020 8:33 AM

Low-cost carrier SpiceJet has inked a pact with Go Digit General Insurance Ltd to offer passengers an insurance cover of up to Rs 3 lakh for COVID-19 treatment. The policy cover will be valid for a period of one year.

Under the policy, passengers can opt for insurance cover ranging between Rs 50,000 and Rs 3 lakh at a premium for Rs 443-Rs 1,564 a year. The charges are inclusive of GST, the airline said.

The insurance covers hospital expenses and all pre and post-hospitalisation expenses for 30 and 60 days respectively. The cover also includes tests, medication, and consultations upon testing positive for COVID-19.

"SpiceJet has joined hands with Go Digit General Insurance Limited through its Digit Illness Group Insurance Policy to offer this insurance cover that will further boost the confidence and morale of passengers," the airline said, adding that the insurance has no restrictions on room or ICU rent.

The insurance cover will include all types of hospitals including private, military, army, government, among others.

"While making a claim, customers can either opt for a cashless claim post positive diagnosis report of COVID-19 or a reimbursement claim. Under cashless, the amount is settled with the hospital or the provider directly whereas, in case of a reimbursement claim, the claim amount is transferred to the customer’s bank account," the airline added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equinor Reportedly Faces Major Losses After US Halts New York Wind Project
Equinor Reportedly Faces Major Losses After US Halts New York Wind Project
May 25, 2025
11:23 AM EDT, 04/30/2025 (MT Newswires) -- Equinor ( EQNR ) could lose billions of dollars after the US government stopped its offshore wind project near New York, multiple media outlets reported Wednesday, citing a company statement. The project, known as Empire Wind, was about 30% finished when the Interior Department halted it on April 16, citing inadequate environmental review,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Petrobras Total Q1 Production Slightly Down Year-on-Year
Petrobras Total Q1 Production Slightly Down Year-on-Year
May 25, 2025
11:33 AM EDT, 04/30/2025 (MT Newswires) -- Petrobras (PBR) said Tuesday its Q1 total crude oil, natural gas liquids, and natural gas production reached 2.77 million barrels of oil equivalent per day, down 0.2% from a year ago and up 5.4% from the previous quarter. Crude oil and NGL production in Brazil averaged 2.21 million barrels per day, down 1%...
Bristol-Myers' New Injection Version of Opdivo Gets UK Approval
Bristol-Myers' New Injection Version of Opdivo Gets UK Approval
May 25, 2025
11:32 AM EDT, 04/30/2025 (MT Newswires) -- Bristol-Myers Squibb's ( BMY ) new under-the-skin injection version of cancer drug Opdivo has received approval from the UK's Medicines and Healthcare products Regulatory Agency, the regulator said Wednesday. The agency said the new version of the drug offers a quicker administration option for eligible patients. Common cancers like lung, bowel, kidney, bladder,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved